FDA Warning Letters and Social Media Compliance Lessons

FDA warning letters and social media compliance illustration with pharmaceutical marketing governance, regulatory review workflow, and MarketBeam branding.

Learn how FDA warning letters pharma help pharmaceutical organizations strengthen regulatory compliance. This guide explains FDA enforcement, promotional violations, misleading claims, corrective action, and pharmaceutical marketing compliance, while showing how MarketBeam helps regulated teams streamline governance, approvals, and compliant social media management.

Webinar

AI and Social in Life Sciences: What’s Real, What’s Fluff, and What’s Next

Life Sciences leaders will share balancing high-impact social marketing with steady compliance measures in this new era of AI.

Pushpa Ithal

Pushpa
Ithal

CEO, MarketBeam

Abbie Jones

Abbie
Jones

Marketing Communications and Brand, Philips

Nikki Wolfert

Nikki
Wolfert

Head of Partnerships, MarketBeam

Julie Eunyoung B.

Julie
Eunyoung

Assistant General Counsel, Sanofi

John Lerch

John
Lerch

Senior Director, Strategy, Veeva MedTech